David D. Chang

Director & President and CEO

Director & President and CEO at Allogene Therapeutics, Inc., filing insider transactions on 2026-03-16.

Total Purchases

—

0 transactions

Total Sales

$118K

1 transaction

Companies Traded

1 total filings

Active Since

2026-03-16

Last: 2026-03-16

Companies

Allogene Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-03-16	ALLO	Sale	47.8K	$2.47	$118K	5.15M	SEC ↗